Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Absorption, Metabolism, and Excretion Study of [14C]AR882 Orally Administered to Healthy Adult Male Subjects

NCT04508426 is registered in ClinicalTrials.gov with Arthrosi Therapeutics as lead sponsor.

NCT NCT04508426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04508426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Absorption, Metabolism, and Excretion Study of [14C]AR882 Orally Administered to Healthy Adult Male Subjects
Lead sponsor
Arthrosi Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
July 16, 2020
Completion date
August 12, 2020
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers